BLOM-SINGER DUAL VALVE INDWELLING VOICE PROSTHESIS, MODELS DV-1600 SERIES, DV-2000 SERIES

K082206 · Helix Medical, LLC · EWL · Sep 4, 2008 · Ear, Nose, Throat

Device Facts

Record IDK082206
Device NameBLOM-SINGER DUAL VALVE INDWELLING VOICE PROSTHESIS, MODELS DV-1600 SERIES, DV-2000 SERIES
ApplicantHelix Medical, LLC
Product CodeEWL · Ear, Nose, Throat
Decision DateSep 4, 2008
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 874.3730
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Blom-Singer Indwelling voice prosthesis is indicated for tracheoesophageal voice restoration following total laryngectomy, when placement, or replacement, of an indwelling voice prosthesis is performed by a qualified, trained medical professional.

Device Story

Blom-Singer Dual Valve Voice Prosthesis is a silicone-based indwelling device for tracheoesophageal voice restoration post-total laryngectomy. It is placed in a surgically created fistula between the trachea and esophagus to divert air through a valve to enable speech. The device features a primary valve and a secondary valve/seat to maintain function if the primary valve leaks. It is intended for indwelling use, eliminating the need for patient-performed daily removal and cleaning. The device is inserted using an inserter stick, flange introducer, and gel caps; the gel cap dissolves to deploy the esophageal flange. The device is used in clinical settings by trained medical professionals. It benefits patients by providing a reliable voice restoration method with reduced risk of accidental dislodgment compared to non-indwelling alternatives.

Clinical Evidence

Bench testing only. No clinical data provided. Functional equivalency was demonstrated through non-clinical tests including airflow, pressure decay, flange retention force, valve attachment integrity, and inserter deployment.

Technological Characteristics

Indwelling voice prosthesis primarily composed of silicone. Features a dual-valve system (primary and secondary valve/seat). Includes accessories: inserter stick, flushing device, flange introducer, gel caps, and lubricant. Designed for placement in a tracheoesophageal fistula.

Indications for Use

Indicated for tracheoesophageal voice restoration in patients following total laryngectomy. Placement or replacement must be performed by a qualified, trained medical professional.

Regulatory Classification

Identification

A laryngeal prosthesis (Taub design) is a device intended to direct pulmonary air flow to the pharynx in the absence of the larynx, thereby permitting esophageal speech. The device is interposed between openings in the trachea and the esophagus and may be removed and replaced each day by the patient. During phonation, air from the lungs is directed to flow through the device and over the esophageal mucosa to provide a sound source that is articulated as speech.

Special Controls

*Classification.* Class II (special controls). The device, when it is a voice amplification device, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 874.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K08 2206 Image /page/0/Picture/1 description: The image shows the logo for Helix Medical. The word "HELIX" is written in large, bold, black letters with horizontal lines running through each letter. Below "HELIX" is the word "MEDICAL" written in smaller, black letters. The logo has a simple and professional design. SEP - 4 2008 ## Helix Medical, LLC 510(k) Summary Blom-Singer Dual Valve Voice Prosthesis #### I NAME OF SUBMITTER Helix Medical, LLC 1110 Mark Ave. Carpinteria, CA 93013 Contact Person: Cynthia Anderson Establishment Registration Number: 2025182 #### II DEVICE NAME AND CLASSIFICATION Proprietary Name: Blom-Singer Dual Valve Voice Prosthesis Common or Usual Name: Voice Prosthesis Class II, 21 CFR 874.3730 The Blom-Singer Dual Valve Voice Prosthesis is neither a life-supporting nor a lifesustaining device. It is not considered an implant. III PREDICATE DEVICES K932120, Blom-Singer Indwelling Low Pressure Voice Prosthesis, April 15, 1994 K945287, InHealth Blom-Singer Indwelling Valved Insert, December 9, 1994 K991587, Blom-Singer Indwelling 2000, June 25, 1999 Related accessories being provided with product: - -inserter stick -flushing device -flange introducer -gel caps -lubricant #### IV DESCRIPTION The Blom-Singer Dual Valve Indwelling Voice Prosthesis is provided for the same indications for use as the other Blom-Singer Indwelling Voice Prosthesis product lines. The Dual Valve Indwelling Voice Prosthesis has been modified from its predicate devices by the addition of a second valve intended to continue to function when leakage occurs in the primary valve. Helix Medical, LLC ● 1110 Mark Avenue ● Carpinteria, CA 93013 USA Tel: (805)684-3304 ● Toll-Free: (800)266-4421 ● Fax: (805)684-1934 www.helixmedical.com {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the logo for Helix Medical. The word "HELIX" is written in large, bold, black letters with horizontal lines running through them. Below the word "HELIX" is the word "MEDICAL" written in smaller, sans-serif letters. The logo has a simple and clean design. 510(k) Summary cont'd. #### V INTENDED USE The Blom-Singer Indwelling voice prosthesis is indicated for tracheoesophageal voice restoration following total laryngectomy, when placement, or replacement, of an indwelling voice prosthesis is performed by a qualified, trained medical professional. #### VI TECHNOLOGICAL REQUIREMENTS The Blom-Singer Dual Valve Indwelling Voice Prosthesis is provided for the same indications for use as its predicate devices, the Blom-Singer Indwelling 2000 Voice Prosthesis, the Blom-Singer Indwelling Low Pressure Voice Prosthesis, and the InHealth Blom-Singer Indwelling Valved Insert. All three devices are indwelling devices primarily made of silicone, designed to provide voicing after total laryngectomy. The voice prostheses are placed in a surgically-created fistula between the trachea and esophagus in order to divert air through the prosthesis valve to create voicing. The use of an indwelling device means that routine removal for cleaning by the patient is not necessary, thus making it easier for the patient to maintain the device while reducing the risk of accidental dislodgment of the device. The Blom-Singer Dual Valve Indwelling Prosthesis has been modified from its predicate devices by the addition of a second valve, consisting of a valve and valve seat, intended to continue to function when leakage occurs in the primary valve. The prosthesis is still primarily silicone. A second modification is the introduction of a slight tension in the voice prosthesis strap when loaded on the inserter with a gel cap containing the prosthesis' esophageal flange. When the gel cap dissolves the inserter moves forward, indicating flange deployment. Functional equivalency tests have been performed on the Blom-Singer prostheses, which demonstrate the equivalency of the valve performance with the predicate designs. Non-clinical tests referenced for a determination of substantial equivalence are Airflow, Pressure Decay, Flange Retention Force, Valve Attachment Integrity and Inserter Deployment. The conclusions drawn from the nonclinical tests demonstrate that the device is safe, as effective, and performs as well or better than the predicate devices. Accessory Devices: The device will be offered with the following accessories: inserter stick, flushing device, flange introducer, gel caps, and lubricant, {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol resembling a caduceus, with three curved lines representing snakes or ribbons. ### Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 SEP - 4 2008 Helix Medical, LLC c/o Ms. Cynthia Anderson VP, Regulatory Affairs 1110 Mark Avenue Capinteria, CA 93013 Re: K082206 Trade/Device Name: Blom-Singer Dual Valve Voice Prosthesis Regulation Number: 21 CFR 874.3730 Regulation Name: Laryngeal prosthesis (Taub design) Regulatory Class: Class II Product Code: EWL Dated: July 31, 2008 Received: August 5, 2008 Dear Ms. Anderson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH)'s) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours. Malvina B. Egleston, und Malvina B. Eydelman, M.I Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ K082206 ## Indications for Use Statement 510(k) Number: not yet assigned K682QOC Device Name: Blom-Singer Dual Valve Voice Prosthesis Indications for Use: The Blom-Singer Indwelling voice prosthesis is indicated for tracheoesophageal voice restoration following total laryngectomy, when placement, or replacement, of an indwelling voice prosthesis is performed by a qualified, trained medical professonal. # PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE, IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 DFR 801.109) OR Over-The-Counter Use Daniel C. Cligg 510(k) Number K082206
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...